Clinical trial
Severe Asthma, MepolizumaB and Affect: SAMBA Study
NCT04680611
Study timeline
Study start (actual)2021-09-09Date precision: day
Registry last updated2026-07-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Severe Eosinophilic Asthmaunresolved
Psychological Distressunresolved
Anxietyunresolved
Depressionunresolved
Psychological Stressunresolved
Psychological Adjustmentunresolved
Psychological Disorderunresolved
Psychosocial Problemunresolved
Psychosocial Stressorunresolved
Psychologicalunresolved
Emotionsunresolved
Emotional Disorderunresolved
Emotional Dysfunctionunresolved
Emotional Distressunresolved
Adjustmentunresolved
Adjustment, Emotionalunresolved
Coping Behaviorunresolved
Interventions
Sponsors & collaborators
Portsmouth Hospitals NHS Trustcollaborator
University of Derbycollaborator
Glasgow Gartnavel General Hospitalcollaborator
Hull University Teaching Hospitals NHS Trustcollaborator
Aberdeen Royal Infirmarycollaborator
Mid Yorkshire Teaching NHS Trustcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04680611 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.